HeartSciences Inc.
HSCS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | -$0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -76.6% | 261.2% | -64.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.8% | 67.3% | 45.7% | 45.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -187,053.3% | -33,096.7% | -118,139.8% | -30,822.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -201,499.5% | -35,511.9% | -9,531,151.3% | -31,851.8% |
| EPS Diluted | -9.34 | -18.74 | -6,173.88 | -137.94 |
| % Growth | 50.2% | 99.7% | -4,375.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |